Biosynex SA operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other
pharmaceutical manufacturers in Europe:
sales of 8.20 million Euro [US$9.20 million]
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
(31.81 million Turkish Liras [US$8.94 million]
Immunodiagnostic System HDQ
based in the United Kingdom
(£38.31 million [US$49.68 million]
of which 100%
was Medical Diagnostic).
During the year ended December of 2016, sales at
Biosynex SA were 27.00 million Euro (US$30.30 million).
increase of 34.1%
versus 2015, when the company's sales were 20.13 million Euro.
This was the fifth consecutive year of sales increases at Biosynex SA
(and since 2011, sales have increased a total of 2,470%).